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Summary 
The E3/19K glycoprotein of adenovirus functions to diminish recognition of adenovirus-infected 
cells by major histocompatibility complex class I-restricted cytotoxic T  lymphocytes (CTLs) 
by binding intracellular class I molecules and preventing them from reaching the plasma membrane. 
In the present study we have characterized  the nature of the interaction between E3/19K and 
the H-2K  d (K  d) molecule. An E3/19K molecule genetically engineered to terminate six residues 
from its  normal  COOH  terminus  (AE19),  was  found to  associate  with  K d in  a  manner 
indistinguishable from wild-type E3/19K. Unlike E3/19K, however, AE19 was transported through 
the Golgi complex to the plasma membrane, where it could be detected biochemically and 
immunocytochemically  using a monodonal antibody specific for the lumenal domain of E3/19K. 
Importantly, AE19 also differed from E3/19K in being unable to prevent the presentation of 
Ka-restricted  viral proteins to CTLs. This is unlikely to be due to AE19 having a lower avidity 
for K d than E3/19K,  since AE19  was able to compete with E3/19K for K a binding, both 
physically, and functionally in nullifying the E3/19K blockade of antigen presentation. These 
findings indicate that the ability of E3/19K to block antigen presentation is due solely to its 
ability to retain newly synthesized class I molecules in the endoplasmic reticulum. 
M 
HC class I-restricted CTLs recognize virus-infected cells 
and release soluble factors that either lyse the cell or 
have direct or indirect antiviral  activities.  The specificity of 
triggering this response is conferred by the TCR, which binds 
class I molecules on the virus-infected cell complexed to linear 
determinants from viral proteins. Under normal conditions, 
these determinants are derived from newly synthesized viral 
proteins present in the cytosol of virus-infected cells (1-3). 
Perhaps the most compelling evidence that CTLs are able 
to reduce the reproductive capacity of viruses is the existence 
of viral proteins, nonessential to viral replication, that diminish 
the presentation of viral antigens to CTLs. The best charac- 
terized of these proteins is the E3/19K glycoprotein (E19) 
encoded by some adenovirus serotypes. E19 is a resident en- 
doplasmic reticulum (ER) 1 glycoprotein expressed early in 
adenovirus infection that forms a tight complex with most 
human MHC  class I  allomorphs,  preventing them from 
reaching the cell surface. This prevents CTLs from recog- 
nizing viral proteins synthesized after synthesis of El9 has 
commenced (4-6),  presumably because antigens processed 
from the cytosol must associate with newly synthesized class 
t Abbreviations  used  in  this paper:  BFA, brefeldin A;  ER,  endoplasmic 
reticulum; GC, Golgi complex; HA, hemagglutinin; NP, nucleoprotein; 
NS1, nonstructural  1; PB2, basic polymerase 2; Vac, vaccinia virus. 
I molecules in an intracellular location (7-9). The retention 
of E19 in the ER requires the presence of the six amino residues 
that constitute its cytosolic COOH terminus. These residues 
(DEKKMP) act as a positive signal for ER retention, since 
their transfer  to the COOH terminus of other type I-an- 
chored membrane glycoproteins confers ER retention (10). 
Although adenovirus is a human pathogen, E19 can also 
bind some mouse class I MHC allomorphs (11). This is not 
totally unexpected given the close sequence homology be- 
tween human and mouse class I molecules. The differential 
binding of El9 to mouse class I aUomorphs has been exploited 
to determine that residues in or near the antigen binding groove 
of class I molecules can influence the ability of E19 to bind 
class I molecules in the ER (12, 13). This finding raises the 
possibility that E19 binds to this region of class I molecules, 
and perhaps prevents antigen association with dass I molecules. 
Previously, we showed that mouse ceils infected with a 
vaccinia virus (Vac) recombinant expressing the E19 glyco- 
protein exhibit a deficit in presentation of newly synthesized 
proteins in association with some mouse class I allomorphs. 
The extent of the deficit correlated with the degree to which 
the allomorphs co-precipitated E19 from detergent extracts 
of 35S-methionine-labeled cells, and was most pronounced 
with K a, which bound El9 in an equimolar complex (6), 
and failed to reach the cell surface. These findings indicated 
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associate with newly synthesized class I molecules during their 
transport to the cell surface. 
In the present study we further characterize the interac- 
tion of EI9 with class I molecules. We have produced a vac- 
cinia virus (Vac) recombinant expressing a truncated El9 mol- 
ecule that is not retained in the EP,, but maintains a high 
affinity for K a.  Using this recombinant we show that the 
truncated E19 does not block the exocytosis of class I mole- 
cules, and does not affect the presentation of viral antigens 
processed  by the cytosolic route. 
Materials  and Methods 
Cells and Antibodies.  Murine mastocytoma P815 (H-2  a) cells 
were maintained in RPMI supplemented with 7% (vol/vol) FCS, 
murine fibroblastoid L929 cells (H-2  k) in DMEM with 7% FCS, 
and hybridoma cells in IMDM with 7%  FCS. The antibody- 
producing hybridomas, SF1-1.1.1 (HB159) (anti-K  d) and 16-1-11N 
(HB 16) (anti-K~), were obtained from the American Type Cul- 
ture Collection (Ikockville, MD) and maintained in IMDM with 
7% FCS. 
Monoclonal  Anti-E19 Antibody.  Splenocytes  derived from 
BALB/cByJ  mice (The Jackson Laboratory, Bar Harbor, ME), im- 
munized first with sonicated E19-Vac (6) -infected mouse spleen 
cells and 3 wk later with sonicated adenovirus 5-infected human 
KB cells, were fused with SP2 myeloma cells. An E19-specific 
antibody-producing hybridoma was identified by immunoperoxi- 
dase screening of E19-Vac-infected cells. After cloning, this hy- 
bridoma (Twl.3) continued to produce an antibody of the 3'3 sub- 
type that specifically  precipitated both E19 and AE19 (Fig. 1 b). 
Immunofluorescence  and Cytofluorography.  For cytofluorography, 
cells were infected with Vac recombinants for 4 h at 37~  Viable 
cells or cells fixed and permeabilized  by brief incubation with 70% 
ethanol were washed twice and incubated with mAb diluted in 
PBS, 1% BSA, 1% azide at 4~  for 40 rain. Cells  were then washed 
twice with PBS, incubated at 4~  for 40 min with fluorescein- 
conjugated rabbit anti-mouse Ig (Dako Corp., Carpinteria, CA), 
washed twice, and their fluorescence quantitated using an Epics 
cytofluorograph (Coulter Electronics, Hialeah, FL). For immuno- 
fluorescence  microscopy,  infected P815 cells  were centrifuged onto 
acid-cleaned D-mm glass coverslips in a 24-well plate. After air 
drying, cells were fixed for 20 rain in 0.5% (wt/vol) paraformalde- 
hyde and permeabilized by the addition of 0.1% (wt/vol) saponin 
during all subsequent incubations. For colocalization studies with 
Con A, ceils  were incubated for 90 win at 40C with Twl.3, washed 
twice, and incubated  for 90 min at 4~  with fluorescein-conjugated 
rabbit anti-mouse Ig alone or with rhodamine-conjugated Con 
A. For double immunofluorescence studies, cells were incubated 
with a rabbit antisera raised to MG160, a resident protein of the 
medial Golgi complex (GC)  (14, 15), followed by fluorescein- 
conjugated goat anti-rabbit IgG. To block free antibody binding 
sites on the goat antibody, rabbit serum was added for 10 rain at 
room temperature, followed by Twl.3 anti-E19 antibody culture 
supematant diluted 1:3. Finally,  rhodamine-conjugated  anti-mouse 
IgG was added.  Coverslips  were mounted in Mowiol-PBS  containing 
5% (wt/vol) 1,4 diazabicyclo[2.2.2]octane  to retard fading. Cells 
were examined using an Axiopliot photomicroscope (Carl Zeiss, 
Inc., Thoruwood, NY) equipped with appropriate filters to gate 
red and green fluorescence. Images obtained with a 100x plan- 
neofluor objective were captured with a video camera (C2400-08 
SI'I~ Hamamatsu, Hamamatsu City, Japan). After digital processing 
with an image processor (DVS-3000; Hamamatsu), the images  were 
transferred to a Macintosh II computer and further enhanced in 
the Macintosh II using the Adobe Photoshop program to change 
eight-bit grey scale images into eight-bit red or green images. The 
images were then printed separately  or superimposed  using a Sony 
Mavigraph color video printer. 
Construction ofVaccinia  Recombinants.  To produce AE19-Vac, two 
synthetic oligonucleotides were used, a 30-base 5' primer corre- 
sponding to nucleotide 1394-1414 of the published E19 sequence 
(16) and encoding a SalI digestion site and Kozac sequence (17), 
and a 34-base 3' primer corresponding to E19 nucleotide 1856-1875 
followed by nucleotides encoding two stop codons, Nod restric- 
tion site, and then 10 nucleotides corresponding to El9 nucleotide 
1876-1885. Primers were used in the PCR using the pJC1 plasmid 
(6) containing the E19 gene. The PCR product was gel purified 
and digested with SalI and NotI restriction enzymes, and ligated 
into the SalI-NotI site of a derivative of pSC.11 modified to con- 
tain these sites to allow directional  ligations (L. E. Eisenlohr, manu- 
script submitted for publication). Vaccinia  recombinants were pro- 
duced using this plasmid as described (6). The sequence of the 
AE19-Vac was confirmed by DNA sequence analysis  of the plasmid 
DNA corresponding to the entire AE19 gene (data not shown). 
Cell Labeling and Immunoprecipitation.  Cells  infected with vac- 
cinia recombinants were incubated in methionine-free medium for 
30 rain at 37~  and radiolabeled  for 10 rain at 37~  by incubating 
cells at  a concentration of 107 cells/ml with 100-200/zCi  35S- 
methionine (Amersham Corp., Arlington Heights, IL). In pulse- 
chase experiments, cells were incubated after radiolabeling with 
medium supplemented  with 5 mg/ml methionine for the indicated 
times at 37~  For each sample, at least 2 x  106 labeled cells were 
lysed in PBS (pH 8.0), containing 0.5% NP-40, 1 mM PMSF at 
4~  for 20 rain. Extracts were centrifuged at 15,000 g and the 
supernatants incubated with protein A-Sepharose beads (Pierce 
Chemical Co., Rockford, IL) loaded with mAbs. Half of the im- 
munoprecipitates were digested overnight at 32~  with endo H 
(Boehringer  Mannheim  Biochemicals, Indianapolis, IN).  Im- 
munopredpitates were analyzed  on 12% polyacrylamide  gels using 
the buffer system of Laemmli (18). Gels were fixed and incubated 
with Amplify (Amersham Corp.) before drying under vacuum. 
Dried gels  were exposed  to preflashed  Kodak  XAR-5 film at - 70~ 
Cytotoxicity Assay.  P815 (2  x  106) cells were infected with 
vaccinia recombinants for 3 h and labeled for 1 h with NaSlCrO4 
(Amersham Corp.). Radiolabeled cells were incubated for 4 h at 
37~  with antiinfluenza effector  cells. Effector cells were obtained 
from cultures of splenocytes  from influenza A/Puerto Rico/8/34 
(H1N1) (PR8) hemagglutinin (Hl-vac), nudeoprotein  (NP-vac), 
nonstructural 1 (NSl-vac), or basic polymerase  2 (PB2-vac) recom- 
binant vac-immunized  BALB/cByJ  mice restimulated in vitro with 
PR8 (19). The amount of 51Cr released into the medium was de- 
termined by gamma radiation counting. Lysis  of uninfected target 
cells ranged from 2 to 18% and was subtracted from all values. 
Experimental  values  represent the average of the triplicates; all values 
had a SEM of <4% of the specific release. The percent 5~Cr re- 
lease was calculated as follows: 100x [(experimental  cpm -  spon- 
taneous [no splenocytes] cpm)/(total  [detergent] cpm  -  sponta- 
neous cpm)]. Spontaneous  release values  were always  <25% of total 
release. 
Lactoperoxidase  Iodination.  Cells  (107) infected with vac recom- 
binants for 6-7 h were washed three times in PBS and resuspended 
in 0.8 ml PBS supplemented with 5 ram glucose, 1 mCi Na~ZSI 
(New England Nuclear, Boston, MA), 1 U/m1 hctoperoxidase, and 
5 U/ml glucoseoxidase.  After a 5-15-rain incubation at room tem- 
perature,  an  additional  1  U/ml  lactoperoxidase and  5  U/m1 
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15 rain at room temperature, washed twice in PBS, 10 mM NaI, 
lysed in extraction buffer, and the extracts immunoprecipitated as 
described above. 
Results 
Production and Characterization of  AE19-Vac and an E19-specific 
mA~  To examine whether E19 blocks antigen assodation 
with K d requires  the uniform expression of high levels of 
E19 nonconstitutively  in target cell populations. The expres- 
sion vector most suited for this purpose is Vac, which also 
provides the advantage of allowing coexpression of additional 
foreign proteins by simply co-infecting cells with multiple 
Vac recombinants. We therefore constructed a Vac recom- 
binant that expresses an E19 glycoprotein without the six 
COOH-terminal  amino  acids  required  for  ER  retention 
(AE19-Vac). A rabbit antiserum raised to a synthetic peptide 
corresponding to the 15 COOH-terminal amino acids of El9 
that effidently precipitates E19 failed to precipitate AE19 from 
3SS-methionine-labded  AE19-Vac-infected P815 cells (Fig.  1 
a). This confirmed that the COOH terminus was altered in 
AE19,  and indicated that we could not use this antiserum 
to characterize  AE19-Vac. To detect AE19 we produced a B 
cell hybridoma (Twl.3) secreting a mouse mAb of the 3,3 
subtype that recognized both El9 and AEt9 (see Materials 
and Methods). As seen in Fig. 1 b, the Twl.3 mAb precipi- 
Figure  1.  Characterization  of anti E19 mAb. (a and b) P815 cells were 
infected with E19-Vac or AE19-Vac  for 2 h and labeled for 10 min in asS- 
methionine. Detergent extracts were immunoprecipitated  with protein 
A-Sepharose beads that had been loaded with (a) a rabbit antiserum specific 
for  the  COOH  terminus of E19  or  (b)  Twl.3  anti-E19  mAb.  Im- 
munopredpitates were digested with endo H  as indicated and analyzed 
by SDS-PAGE.  Endo H-resistant (E19r, AE19r) and Endo H-sensitive (E19s, 
AE19s) forms of the El9 protein are indicated. (c) Similarly, uninfected 
cells (lanes 1 and 2) or E19-vac  infected cells (lane 3) were labded for 3 h 
with 3sS-methionine  and detergent extracts were immunoprecipitated with 
anti-K  d class I mAb (lane I) or Twl.3 anti-E19 mAb (lanes 2 and 3). 
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tated both E19  and AE19  from detergent extracts  of 35S- 
methionine-labeled AE19-Vac  and E19-Vac-infected  ceils, respec- 
tively, as determined by SDS-PAGE analysis of precipitates. 
This also revealed that AE19 migrated slightly faster  than 
E19, which is consistent with its COOH-terminal deletion. 
The antibody is specific for the lumenal domain of E19, since, 
as described brow, it binds to viable cells expressing AE19 
on the plasma membrane. 
The Twl.3 mAb precipitated from E19-Vac-infected cell 
extracts an additional protein with an apparent molecttlar mass 
of 88 kD (Fig.  1 c, lane 3). This is a cellular protein, since 
it was also speeificaUy  precipitated from uninfected cells (Fig. 
1 c, lane 2). It is potentially of great interest as it could repre- 
sent a cellular  homologue of E19. We have not been able, 
however, to demonstrate that this protein interacts with class 
I molecules, since class I molecules do not co-precipitate with 
the protein (the expected location of class I heavy chains can 
be determined from comparison with lane I, which repre- 
sent immunoprecipitation with  a Ka-spedfic  mAb),  even 
after chemical crosslinking of detergent extracts (not shown). 
It does not represent the 88-kD class I-associated protein 
identified by Degen and Williams (20) (Williams, D. B., per- 
soual communication). The protein might be expressed only 
at  low  steady-state  levels in  cells,  since  in  indirect  im- 
munofluorescence, the Twl.3 mAb does not stain uninfected 
cells above background levels obtained in the absence of a 
first antibody. It remains to be established whether the reac- 
tivity of 88-kD protein with Twl.3 is fortuitous or indicates 
a true functional or evolutionary relationship with E19. 
Immunolocalization of El9 and AE19.  The cdlular local- 
ization of AE19 and E19 in Vac recombinant-infected P815 
ceUs was examined using the Twl.3 mAb in indirect double 
immunofluorescence  of fixed and permeabilized calls attached 
to coverslips. In E19-vac-infected  cells, the Twl.3 mAb stained 
the nuclear membrane and cytoplasmic structures (Fig. 2 a, 
left, red  staining).  A  similar pattern  was  observed using 
rhodamine-Con A, which predominantly stains the ER by 
virtue of it specificity for terminal mannose residues  (Fig. 
2 a, right, green staining). The staining of Twl.3 and Con 
A was largely co-incident as indicated by the yeUow color 
obtained when superimposing the  two images (Fig.  2 a, 
middle). To determine if E19 was also present in the GC, cells 
were double stained with Twl.3 and a rabbit antiserum specific 
for a resident protein of the medial GC (14, 15). The GC 
in P815 cells centrifuged onto coverslips appears as smaU  green 
punctate structures (Fig. 2, b and c, right). Little of this stain 
colocalized with TW1.3 in E19-Vac-infected cells (Fig. 2 b, 
middle). By contrast, TW1.3 clearly colocalized with the anti- 
GC antiserum (Fig. 2 c, middle) in AE19-Vac-infected cells, 
in addition to staining the ER (Fig. 2 c, left). This analysis 
suggested that while E19 was restricted to pre-GC compart- 
ments, AE19 was  transported to the GC. 
To quantitatively determine whether AE19 was transported 
to the cell surface, L929 cells were infected with E19-Vac or 
AE19-Vac for 5 h, stained with Twl.3, and analyzed  using 
a cytofluorograph (Table 1). Using viable cells, Twl.3 bound 
above background  levels to AE19-Vac-,  but not E19-Vac-infected 
cells. The failure to detect E19 on E19-Vac-infected cells is Figure  2.  Immunofluorescence  19calization of E19 and AE19. P815 cells infected with E19-Vac (a and b) or AE19-Vac (c) for 5 h were fixed and 
permeabilized before double  staining  with Twl.3 anti-E19 mAb and Con A (a) or with Twl.3 and a rabbit  antiserum  specific for a resident  protein 
of the medial GC (b and c). The green color (right) represents staining  with the Mg160 antbGolgi antibody (b and c) or Con A  (a), the red color 
(left) represents  staining  with anti-El9.  (Middle) The green  and red images have been merged  to yield yellow color where staining  coincides. 
not due to low levels of  expression, since ethanol-permeabilized 
ceUs actually bound more Twl.3- than AE19-Vac-infected cells. 
Thus,  AE19  but not E19  is transported to  the cell surface 
of Vac recombinant-expressing cells. 
In the same experiment, we examined the ability of E19 
and AE19 to block the surface expression of newly synthe- 
sized K d molecules.  Infection of L929 cells (H-2  k) with a Vac 
recombinant-expressing K d (Kd-Vac) (21) resulted in the ex- 
Table  1.  Transport of Newly Synthesized  K a Is Not Inhibited  by  the AE19 Protein 
Coinfection  of L929 cells 
Immunofluorescence percent  positive  (mean  intensity) 
Live cells  Permeabilized 
K a  E19  K d  E19 
Kd-Vac  96.1  (15.5)  2.7  (7.8)  88.2  (8)  4.3  (6.4) 
Kd-Vac  +  E19-Vac  3.0  (6.6)  11.6  (15.4)  81.2  (9.8)  89.4  (13) 
Kd-Vac  +  AE19-Vac  86.2  (9.4)  49.5  (6)  86.1  (10)  80.4  (9.6) 
E19-Vac  1  (6.7)  2.7  (9)  4.2  (9.2)  93.7  (12.5) 
AE19-Vac  1.2  (9)  54  (7)  3.7  (8.4)  83  (8.3) 
L cells were infected with Vac recombinants for 4 h, and live cells and cells fixed and permeabilized in 70% ethanol were stained with anti-K  a SFI-1.1.1 
or the Twl.3  and analyzed via cytofluorography. 
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detected on the surface of cells co-infected with Ka-Vac and 
E19-Vac, while it was detected in cells co-infected with K d- 
Vac and AE19-Vac,  albeit at reduced levels.  The lack of K d 
surface expression in cells co-infected with E19-Vac and K d- 
Vac is not due to low expression of the K d gene,  since per- 
meabilized cells expressed similar amounts of K d as cells in- 
fected only with Kd-Vac, or with Kd-Vac and AE19-Vac. The 
finding that  the surface expression of newly synthesized K a 
was  not  significantly  inhibited  by  AE19-vac  was  further 
confirmed  by  the  immunoprecipitation  of K d from  L929 
cells co-infected with Ka-Vac and AE19-Vac, whose cell sur- 
face proteins were labeled by lactoperoxidase catalyzed iodi- 
nation  (data  not  shown). 
Biochemical  Analysis of  A E19 Intracellular  Transport  and Binding 
to K a.  To biochemically characterize  the intracellular  traf- 
ficking of E19 and AE19, 3SS-methionine  pulse-labeled P815 
cells  were chased for various  times  at  37~  detergent  ex- 
tracted, and immunoprecipitated with Twl.3 anti-E19 mAb 
or with an anti-H-2K d mAb. Before analysis by SDS-PAGE, 
half the  samples were treated  with  endo H  to remove the 
simple oligosaccharides characteristic of glycoproteins before 
they are modified by enzymes that reside in the medial GC. 
Deglycosylation by endo H  results in an easily detectable in- 
crease in the mobility of K s and E19 in SDS-PAGE, and in- 
dicates proteins  in a post-ER compartment.  The resistance 
of proteins to this mobility shift suggests that they have been 
transported  to  or  through  the  medial  GC. 
Immediately after pulse-labeling,  AE19 was completely sen- 
sitive to endo H  digestion (Fig.  3).  With  increasing  times 
after the pulse,  a subpopulation of AE19 became less sensi- 
tive to digestion with endo H, indicating that at least a por- 
tion  the AE19 can transit  through  the Golgi.  As is typical 
of proteins with mature oligosaccharides,  endo H-resistant 
AE19 migrated with slightly lower mobility than AE19 with 
less mature oligosaccharides.  In contrast,  all the newly syn- 
thesized El9 remained sensitive to endo H digestion over the 
entire  8-h  chase period  (Fig.  3). 
Figure  3.  Transport  of AE19 protein. P815  cells  were  infected  with E19- 
Vac or AE19-Vac  for 2 h and labeled for 10 rain in 3sS-methionine, and 
chased at 37"C for the times indicated. Detergent extracts were immuno- 
precipitated with protein A-Sepharose  beads that had been loaded with 
Twl.3 anti-E19 mAb. Immunoprecipitates were digested with endo H 
as indicated  and analyzed  by SDS-PAGE.  E19r; endo  H-resistant  E19, E19s; 
endo H-sensitive E19. 
Figure  4.  Transport  of class I K  a protein. P815 cells were infected with 
E19-Vac or AE19-Vac  for 2 h and labeled for 10 min in 3sS-methionine, 
and chased at 37~  for the times indicated. Detergent extracts were im- 
munoprecipitated with protein A-Sepharose  beads that had been loaded 
with anti-K  d class I mAb. Immunoprecipitates were digested with endo 
H as indicated and analyzed by SDS-PAGE. Hc. Heavy  chain class I; Lc, 
3z-microglobulin; s, endo H sensitive; r, endo H resistant. 
Immunoprecipitation  of detergent lysates with anti-K  d re- 
vealed  that  newly synthesized  AE19,  like E19,  complexed 
within  the  10-min  pulse to newly synthesized K a,  and re- 
mained bound in an m1:1 ratio over the 4-h pulse period (Fig. 
4). fl2-microglobulin  was co-precipitated from both E19-Vac- 
and AE19-Vac-infected  cells in increasingly greater quantities 
after labeling. Most importantly,  K a synthesized in E19-Vac- 
infected cells remained sensitive to endo H digestion over the 
4-h  chase,  while  K d precipitated  from  AE19-Vac  became 
endo H resistant beginning within 30 min after labeling, and 
increasingly over the next 3.5  h.  K a in cells  infected with 
a control Vac recombinant became almost completely resis- 
tant to endo H digestion within 1 h of synthesis (not shown). 
Since similar amounts of K d and E19 were precipitated from 
E19-Vac- and AE19-Vac-infected  cells, these findings strongly 
suggest that K d associated with AE19 is transported through 
the  GC. 
To further examine the surface expression of E19 and AE19, 
cells were surface iodinated 7 h  after infection with AE19- 
Vac and detergent extracts immunoprecipitated with the Twl.3 
mAb.  Immunoprecipitates  were then  treated with  endo H 
or left untreated,  and  analyzed by SDS-PAGE.  As seen  in 
Fig.  5, iodinated AE19 was easily detected by this method. 
To determine whether this labeled pool of AE19 was truly 
present  on the cell surface and not in an intracellular  loca- 
tion, AE19-Vac-infected  cells were incubated with brefeldin 
A  (BFA) to prevent the surface expression of AE19 (8).  In 
this case far less AE19 was iodinated.  This was due to the 
intracellular  location of AE19 in these cells,  not low levels 
of AE19 expression,  since labeling of AE19 was completely 
restored by removing the BFA and incubating  cells  for 60 
min at 37~  in the presence of protein synthesis inhibitors 
to prevent synthesis of additional AE19.  It can also be seen 
in Fig. 5 that only low levels of E19 were radioiodinated on 
E19-Vac-infected cells. This almost certainly represents intra- 
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binants for 6-7 h were surface radioiodinated using lactoperoxidase. Cells 
were incubated where indicated with BFA from the time of infection. In 
the last two lanes, BFA was removed from cells that were incubated for 
another 1 h at 37~  in the presence of anisomycin at 25 #g/ml to block 
additional protein synthesis. Detergent lysates were immunoprecipitated 
using protein A-Sepharose beads that had been preloaded with Twl.3 
anti-E19 mAb. Immunoprecipitates  were digested with endo H as indi- 
cated, and analyzed by SDS-PAGE. 
cellular  E19,  since similar  amounts  of E19 were radioiodi- 
nated in E19-Vac cells treated with BFA. Thus, these findings 
confirm that E19 is confined to intracellular  compartments, 
while AE19 is able to reach  the cell surface. 
In addition to a major band migrating with the mobility 
expected for AE19, a minor radioiodinated species migrating 
with a mobility intermediate between glycosylated and de- 
glycosylated E19 was precipitated by Twl.3 (marked in Fig. 
5 by an asterisk). A band of a similar mobility was apparent 
at early chase times in 3SS-methionine-labeling experiments 
(Fig.  3). The disappearance of this band upon endo H  treat- 
ment of 3SS-methionine-labeled  lysates (Fig.  3) suggests that 
this species represents AE19 containing only one of the two 
oligosaccharides  normally  added  to E19. 
Treatment  of radioiodinated  AE19  immunoprecipitates 
resulted in three bands,  corresponding  to AE19 with  two, 
one, or zero oligosaccharides.  Note that endo H-treated AE19 
with a single oligosaccharide migrated with a lower mobility 
than the adjacent band in the non-endo H-treated lane, which 
is consistent with expected mobility difference between AE19 
with a mature vs. immature oligosaccharide.  This mobility 
difference indicates  that this species is derived from AE19 con- 
taining two oligosaccharides.  At least a portion of AE19 com- 
pletely deglycosylated by endo H  must also be derived from 
AE19 containing two oligosaccharides since there is more of 
this  material  than  of  the  singly  glycosylated,  non-endo 
H-treated AE19. Thus, AE19 is able to reach the cell surface 
with one or both of its oligosaccharides in immature form. 
Expression of AEl9 Protein Does Not Affect Antigen Presen- 
tation.  Four influenza virus proteins are recognized by CTL 
from  H-2  d mice:  hemagglutinin  (HA)  and  nudeoprotein 
(NP)  are recognized in  association with K a,  nonstructural 
1  (NS1)  with  L  d,  and basic polymerase  2  (PB2)  with  D a 
Table  2.  AEI9  Does Not Inhibit  the Presentation of 
Influenza  Virus Antigens 
Percent specific 
Coinfection  of P815 cells  Restriction  SlCr release 
H1-Vac  +  E19-Vac  K  d  9  10 
H1-Vac  +  AE19-Vac  64  49 
H1-Vac  +  [LSV-Vac  66  45 
NP-Vac  +  E19-Vac  K  d  9  3 
NP-Vac  +  AE19-Vac  75  56 
NP-Vac  +  RSV-Vac  64  55 
PB2-Vac  +  E19-Vac  D d  35  17 
PB2-Vac  +  AE19-Vac  36  9 
PB2-Vac  +  RSV-Vac  29  13 
NS1-Vac  +  E19-Vac  L  d  22  10 
NS1-Vac  +  AE19-Vac  49  29 
NS1-Vac  +  RSV-Vac  51  27 
p815 cells were  co-infected for 4 h  at 37~  with 20 PFU per cell of 
E19-Vac, AE19-Vac, or respiratory  synctial virus-Vac (RSV-Vac),  and 
Vac recombinants expressing the influenza virus genes encoding either 
nucleoprotein  (NP-Vac) or hemagglutinin (H1-Vae). Na51CrO~-labeled 
cells were incubated  for 4 h  at 37~  with antiinfluenza effector cells; 
experimental values represent the average of triplicates. E/T ratios were 
58:1 and 7:1,  respectively. 
(19). We previously found that co-infection of cells with E19- 
Vac and Vac recombinants expressing the individual viral pro- 
teins results in complete inhibition  of presentation  of HA 
and NP, partial inhibition of NS1, and very slight inhibition 
of PB2.  To establish whether  the AE19 protein behaved in 
a similar fashion, we repeated this experiment using AE19- 
Vac and CTL specific for the individual  influenza virus an- 
tigens.  AE19 did not inhibit  the presentation  of any of the 
influenza virus antigens,  since cells co-infected with AE19- 
Vac were lysed at similar levels as cells co-infected with a control 
Vac recombinant expressing a protein from respiratory syn- 
cytial virus (Table 2). In the same experiment,  E19 behaved 
as previously observed, efficiently blocking presentation  of 
Kd-restricted  HA and  NP,  partially  blocking  Ld-restricted 
NS-1,  and  not  affecting Da-restricted  PB2. 
A trivial explanation for the failure of AE19 to block an- 
tigen presentation  of HA and NP is that  it forms  a more 
tenuous complex with K a than does E19. Although this did 
not  seem likely based on the equal co-precipitation  of E19 
and AE19 with  K d,  it  was important  to demonstrate  that 
AE19 could compete with E19 for binding of K a, nullifying 
the E19 blockade of antigen presentation.  This was accom- 
plished by co-infecting cells with E19-Vac, AE19-Vac, and Vac 
recombinants expressing HA or NP. As seen in Table 3, co- 
infection with  AE19-Vac completely restored the presenta- 
tion of HA or NP. The recovery of antigen presentation  is 
specifically mediated by AE19, and is not simply attributable 
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Binding Site on Mouse K a 
Percent specific 
Co-infection of P815 cells  SlCr release 
NP-Vac  69  52 
NP-Vac  +  E19-Vac  22  10 
NP-Vac  +  E19-Vac +  AE19-Vac  58  42 
NP-Vac  +  E19-Vac +  P,  SV-Vac  10  5 
H1-Vac  57  25 
H1-Vac  +  E19-Vac  8  10 
H1-Vac  +  E19-Vac +  AE19-Vac  59  34 
H1-Vac  +  E19-Vac  +  RSV-Vac  15  2 
P815 cells  were  co-infected  for 4 h at 37~  with 5 PFU per cell  of  E19-Vac, 
20 PFU/cell of Vac recombinants expressing the influenza  virus genes 
encoding either nucleoprotein  (NP-Vac) or hemagglutinin  (H1-Vac), and 
100 PFU per cell of either AE19-Vac or RSV-Vac. NaSlCrO4-1abeled 
cells were incubated  for 4 h at 37* with antiinfluenza  effector  cells; ex- 
perimental values represent the average of triplicates. E/T ratios were 
80:1 and 9:1, respectively. 
to the effects of Vac superinfection, since co-infection with 
a similar dose of a control Vac recombinant had no effect 
on antigen presentation. Thus, these finding suggest that El9 
does not block antigen association with dass I molecules. 
Intracellular Dimerization of  El9 and AE19.  It is likely that 
E19 exists in cells as multimers, since a subpopulation mi- 
Figure 6.  AE19  and El9 proteins  can form  heterodimers.  P815 cells  were 
infected for 3 h at 37~  with EIg-Vac or A19-Vac alone, or co-infected 
at the indicated  ratios. Cells were labeled  for 10 rain in 35S-methionine, 
and extracted and immunoprecipitated  with protein A-Sepharose  beads 
loaded with Twl.3 anti-E19 mAb (a) or anti-K  a class I mAb (b). Half 
of the immunoprecipitates  were digested  with endo H as indicated, and 
analyzed  by SDS-PAGE  under nonredueing  conditions.  (Inset)  ww, wild- 
type E19 homodimer;  wA, wild-type  and AE19 heterodimer;  AA, AE19 
homodimer; *immunoprecipitated  with anti-E19 mAb; **immunopre- 
cipitated with anti-K  a mAb. 
grates as dimers when analyzed in SDS-PAGE under non- 
reducing conditions. It was therefore possible that the effect 
of AE19 on E19-mediated blockade of antigen presentation 
was due to the formation of mixed dimers unable to bind 
to  K a.  To  examine this  possibility,  we  characterized  the 
ability of El9 and AE19 to form mixed dimers. In P815 ceils 
infected with E19-Vac or AE19-Vac alone, the monomeric and 
dimeric forms of the respective proteins precipitated by Twl.3 
from pulse-labeled extracts could be completely distinguished 
from each other based on the higher mobility of AE19 (Fig. 
6 a). In cells co-infected with equal doses of  E19-Vac and AE19- 
Vac,  a third band, presumably a heterodimer, was present 
halfway between the observed bands of the E19 and AE19 
directs.  The  heterodimer  was  more  dearly  visible  after 
deglycosylation  by endo H digestion, which is expected since 
oligosaccharides generally decrease the sharpness  of protein 
migration in SDS-PAGE. The proportion of each of the spe- 
cies in cells infected under these conditions, or with 10-fold 
excess of one of the recombinants, approximates a binomial 
distribution of the three species, which suggests that E19 and 
AE19-Vac randomly associate with each other. 
In parallel,  extracts prepared from co-infected cells were 
immunoprecipitated with a Ka-specific mAb (Fig. 6 b). Both 
monomeric and dimeric forms of the E19 and AE19 were 
co-precipitated with  K a.  Most  importantly,  heterodimers 
formed between the E19 and AE19 protein were also present, 
and therefore are fully capable  of binding to class I mole- 
cules.  Therefore, the observed competition between AE19 
and E19 in blocking antigen presentation cannot be ascribed 
to the formation of heterodimers incapable of binding to K d. 
Discussion 
The goal of the present study was to determine whether 
El9 blocks the association of antigen with class I molecules. 
Our strategy was to engineer a modified El9 glycoprotein 
that maintains its binding to class I molecules but is no longer 
retained in the ER. It had been shown previously that reten- 
tion of El9 in the ER could be abrogated by altering residues 
in the COOH terminus of El9, a portion of the molecule 
that is believed to reside in the cytosol (22, 23). As removal 
of the entire cytosolic domain of El9 was found to reduce 
its binding to class I molecules (24), it was important to make 
a less severe alteration. There is some controversy regarding 
the exact features of cytosolic domain that confer ER reten- 
tion.  A  recent report,  however,  clearly demonstrated that 
transfer of the six terminal residues  of El9 to other mem- 
brane glycoproteins greatly retarded their exit from the ER 
(10).  We therefore decided to delete only the six terminal 
residues  from El9 in creating the AE19 protein. 
By immunochemical and biochemical analysis, we demon- 
strated that AE19 is transported to the plasma membrane, 
confirming the importance of the cytosolic COOH-terminal 
residues in mediating EP, retention. Some of the cell surface 
AE19 contained carbohydrates sensitive to digestion with endo 
H. This indicates either that the oligosaccharides are partially 
resistant to modification by enzymes in the GC, or that a 
subpopulation of AE19 does not traverse the entire GC. The 
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endo H-resistant oligosaccharide indicates that the first mech- 
anism accounts for some, if not all,  of the oligosaccharide 
heterogeneity. The failure of GC enzymes to modify AE19 
oligosaccharides is probably unrelated to its association with 
class I molecules, since we have observed a similar heteroge- 
neity in L929 cells, which do not have class I molecules that 
tightly associate with AE19 or E19 (our unpublished results). 
Observations of similar heterogeneity in secreted forms of 
E19 expressed by insect cells,  which do not possess  MHC 
genes, support this conclusion (25). Instead, it is more likely 
that  failure  of GC  enzymes  to  modify AE19-associated 
oligosaccharides is due to an intrinsic limit to their accessi- 
bility, perhaps because they are located in a more internal 
position after the assembly of AE19 into oligomers. 
The maturation of E19-associated  oligosaccharides, while 
incomplete, still serves as a measure of E19 export from the 
ER.  By this criteria, AE19 is transported relatively slowly 
from the ER,  with a half time of "~4 h. The half time of 
K d acquisition of endo H  resistance in  AE19-Vac-infected 
cells demonstrated similar kinetics. This represents an ~10- 
fold increase over the half time of K d export in Vac-infected 
cells,  and indicates that AE19 remains complexed with K a 
at least until K a has passed  through the medial GC. 
This latter point bears on a question central to the interpre- 
tation of the inability of AE19 to block antigen presentation: 
how tight is the association of AE19 with K d in the com- 
partment where antigen association normally occurs? Two 
findings suggest that AE19 binds K d with a similar avidity 
as E19 in early e.xocytic compartments. First, similar amounts 
of E19 and AE19 co-precipitate with K d. Second, AE19 is 
able  to  compete  with  E19  both  biochemically  for  K d 
binding, and functionally, to reverse the effect of E19 on an- 
tigen presentation. Thus, it appears  that AE19 binds to K a 
with high affinity at least until the complex has passed through 
the medial GC. The stability of the complex during the latter 
stages  of exocytosis remains to be established. As it is be- 
lieved that antigens associate with class I molecules in an ex- 
ocytic compartment proximal to the medial GC (6-9), it seems 
unlikely that the possible dissociation of AE19 from K a in 
a late exocytic compartment would account for its failure to 
block antigen association. Ultimately, however, to definitively 
establish whether E19 blocks association of antigen with class 
I molecules will require direct examination of the peptide 
binding capacity of E19-class I complexes. 
If AE19 remains in a tight complex with class I molecules 
at the cell surface,  this would mean that E19 binding does 
not interfere with the interaction of class I molecules with 
the TCR. This would suggest that class I heavy chains are 
able to interact with at least  four proteins simultaneously, 
the TCR,  CDS,  B2-microglobulin,  and E19.  In this case, 
as the polymorphic residues in the o~2 domain that influence 
the affinity of E19 for mouse class I molecules are likely to 
be in close proximity to the TCR, it would further imply 
that these residues do not contact E19, but act by inducing 
conformational alterations in other regions of the heavy chain. 
A recent study determined that E19 binding and rapid ex- 
port from the ER of a series of Kd-K  k chimeric molecules 
coordinately mapped to five polymorphic residues in the first 
half of the c~2 domain (13). Based on this finding, it was 
proposed  that E19 interferes with class I export by either 
affecting class I assembly, or by interfering with the interac- 
tion of class I molecules with accessory molecules that posi- 
tively influence class I transport. Given the apparently normal 
binding of AE19 to K d, the transport of AE19-K  d complexes 
to the cell surface and their recognition by CTL strongly 
argue that E19 blocks class I transport solely by virtue of 
its cytosolic ER retention sequence. 
If E19 binds to class I molecules in a fundamentally different 
manner than CD8, B2-microglobulin, antigenic peptides, or 
the TCR, from which cellular gene is E19 derived? E19 ap- 
pears to have its origins among the Ig superfamily of genes, 
with whose members it shares a tenuous homology (26). Pro- 
tein or DNA sequence analysis  of the 88-kD protein that 
reacts with the Twl.3 mAb could reveal that it is the cellular 
homologue of E19. Although this protein has no apparent 
role in class I assembly or transport,  there is no guarantee 
that cellular descendents of the E19 ancestor will have any 
such function. 
There are three general possibilities  for the function of the 
modern cellular descendent(s) of the putative E19 ancestor. 
It might have nothing to do with class I assembly and trans- 
port, it might be one of the gene products known (20) or 
suspected (27) to interact with class I during exocytosis, or 
its interaction with class I genes could remain to be charac- 
terized. Regarding the latter possibility, it is clear that we 
are only beginning to understand the subtleties in the assembly 
and transport of class Ia molecules. Furthermore, the MHC 
encodes many class Ib molecules whose characteristics and 
functions are unknown, and that probably interact with a 
number of undiscovered MHC and non-MHC gene prod- 
ucts, one of which could be descended from the progenitor 
of E19. 
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